Karin Dahlman-Wright was born in Stockholm, Sweden, in 1961. She received a degree in chemical engineering from Chalmers University of Technology, Gothenburg, Sweden, in 1986 and her Ph.D. degree in molecular endocrinology from the Karolinska Institute, Stockholm, Sweden, in 1991. Between 1995 and 2000, she held different line and management positions at Pharmacia and Upjohn focusing on target and drug discovery. Upon returning to academia, she established the Bioinformatics and Expression Analysis Core Facility at the Karolinska Institute. She is presently a Professor of Molecular Endocrinology and the Chairman of the Department of Biosciences and Nutrition, Karolinska Institute, Stockholm, Sweden. She is the author of approximately 100 per reviewed articles. Her research focuses on applying functional genomics and genetic approaches to address the role of nuclear receptors in physiology and disease. A particular focus is on the role of estrogen signaling and estrogen receptors in metabolic disease and breast cancer. The approaches include studies of samples from humans, animal studies, and studies in different cell culture models.
Biography Updated on 28 August 2011